NRXP - NRX Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.1 0.07 (2.26%)	---	---	0.0 (0.0%)	0.09 (2.9%)	0.05 (1.61%)	0.0 (0.0%)	0.0 (0.0%)

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.98
Diluted EPS:
Basic P/E:: -3.2347
Diluted P/E:
RSI(14) 1m:: 100.0
VWAP:: 3.17
RVol:: 0.4691

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	3.12 +0.05 (+1.63%)	Oct 15 13:04
1m	Price increase 1m	3.13 +0.05 (+1.62%)	Oct 15 11:53
1m	Price decrease 1m	3.1 -0.04 (-1.43%)	Oct 15 09:33
1m	Price decrease 1m	3.1 -0.08 (-2.48%)	Oct 15 09:32
1m	Price increase 1m	3.19 +0.09 (+2.9%)	Oct 15 09:30